Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression
Varenicline is a widely used and effective drug for smoking cessation. We previously reported that varenicline aggravates atherosclerosis in apolipoprotein E knockout (ApoE KO) mice. However, it remains unknown whether varenicline affects cardiovascular events in patients with nicotine addiction. He...
Saved in:
Main Authors: | Mitsuhisa Koga (Author), Yuki Kanaoka (Author), Mana Okamoto (Author), Yuki Nakao (Author), Koshun Inada (Author), Saki Takayama (Author), Yasufumi Kataoka (Author), Atsushi Yamauchi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages
by: Mitsuhisa Koga, et al.
Published: (2020) -
LOX-1, OxLDL, and Atherosclerosis
by: Angela Pirillo, et al.
Published: (2013) -
Varenicline is a smoking cessation drug that blocks alveolar expansion in mice intratracheally administrated porcine pancreatic elastase
by: Mitsuhisa Koga, et al.
Published: (2018) -
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
by: Nesreen N. Omar, et al.
Published: (2017) -
Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2021)